Actuate Therapeutics Congratulates Dr. Patricia LoRusso on Being Named AACR President-Elect
<!-- Name:DistributionId Value:8794444 -->
<!-- Name:EnableQuoteCarouselOnPnr Value:False -->
<!-- Name:IcbCode Value:4573 -->…
Browsing Tag
Actuate Therapeutics
Actuate Therapeutics Announces Initiation of a Multicenter Randomized Trial of Elraglusib Plus…
CHICAGO and FORT WORTH, Texas, Feb. 07, 2022 (GLOBE NEWSWIRE) -- Actuate Therapeutics, Inc. (Actuate), a clinical stage biopharmaceutical company, today announced the opening of a randomized study of elraglusib (9-ING-41) plus FOLFIRINOX…